Ursula Kirchmayer, FISPE
Pharmacoepidemiologist
Department of Epidemiology, ASL Roma1,
Lazio Regional Health Service
Rome, Italy
Serving first 3-year term

Fredrik Nyberg, FISPE
Professor of Register Epidemiology
School of Public Health and Community Medicine,
Institute of Medicine, Sahlgrenska Academy, University of Gothenburg
Gothenburg, Sweden
Serving first 3-year term

Lisa Pont, FISPE
Associate Professor & Team Lead Medicines Use Research in
Aged Care (MURAC)
Discipline of Pharmacy, Graduate School of Health
University of Technology Sydney (UTS)
Sydney, Australia
Serving second 3-year term

Jennita Reefhuis
Branch Chief, Birth Defects Branch
National Center on Birth Defects and Developmental Disabilities
Centers for Disease Control and Prevention
Atlanta, USA
Serving second 3-year term

Mary Beth Ritchey, FISPE 
Principal & Owner, Med Tech Epi, LLC, Philadelphia, PA, USA
Associate Research Professor, Center for Pharmacoepidemiology and Treatment Sciences, Rutgers University, New Brunswick, NJ, USA
Serving first 3-year term

Tomoko Kobayashi
Epidemiologist, Real World Evidence, Science & Data Analytics Division, Research & Development, Astrazeneca K.K.
Osaka, Japan
Serving first 3-year term

Mette Nørgaard
Professor in Epidemiology of Urinary Tract Diseases, Department of Clinical Epidemiology
Aarhus University
Denmark
Serving first 3-year term

Jeremy Rassen, FISPE
Co-Founder, President and Chief Science Officer at Aetion, Inc.,
New York, NY
Serving first 3-year term

Montse Soriano Gabarro, FISPE
Head of Epidemiology
Bayer AG
Berlin, Germany
Serving second 3-year term

Shirley Wang, FISPE
Assistant Professor, Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital
Harvard Medical School
Boston, USA
Serving first 3-year term

Jennifer Lund, FISPE
Associate Professor, Department of Epidemiology
University of North Carolina at Chapel Hill
Chapel Hill, USA
Serving first 3-year term

Stine Hasling Mogensen
Senior Advisor
Danish Medicines Agency's Data Analytic Centre
Copenhagen, Denmark
Serving first 3-year term

Daniel Prieto-Alhambra, FISPE
Professor of Pharmaco- and Device Epidemiology
Centre for Statistics in Medicine
Oxford, UK
Serving first 3-year term

Yoshiaki Uyama
Director, Office of Medical Informatics and Epidemiology
Pharmaceuticals and Medical Devices Agency (PMDA)
Tokyo, Japan
Serving first 3-year term

Hongbo Yuan
Scientific Advisor, Evidence Standard
Canadian Agency for Drugs and Technologies in Health
Ottawa, Canada
Serving first 3-year term

Stanley A. Edlavitch, FISPE
University of Missouri School of Medicine
Kansas City, USA